News|Videos|October 2, 2023
Physician disciplinary actions: No national standards
Author(s)Richard Payerchin, Logan Lutton
Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, discusses a lack of a national standard for physician discipline.
Advertisement
In August 2023, Public Citizen, a Washington, D.C.-based nonprofit consumer advocacy group, published the report, “Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2019-2021.” There is no national standard for how states investigate or even what they call physician misconduct, said report coauthor Robert E. Oshel, PhD.
Advertisement
Related to this article
Nolla Health claims it has the nation’s first approval for artificial intelligence to issue initial prescriptions. Physician review comes later.
Medical Economics spoke with MGMA's Madison Hynes about the association's draft bill to ban automatic downcoding, the Patients First Act and AI-run prior authorization in traditional Medicare.
HHS finalizes price transparency updates as employers push insurance vendors to open the books.
Cash payments for GLP-1s are on the rise, according to pharmacists surveyed by Buzz Health.
Medicine has never moved this fast. How much of the next decade has already been decided, and what’s still open?
Patients who received weekly plant-based grocery packages from a primary care clinic's food pantry for an average of 2.7 years saw dose-dependent drops in diastolic blood pressure, weight and BMI, but no significant change in hemoglobin A1c, a Mass General Brigham study found.
Medical Economics spoke with health care attorney Tatiana Melnik, J.D., about vendor contracts, patient consent and the malpractice questions physicians could face next.
Advertisement
Advertisement
Trending on Medical Economics
1
The 10 biggest federal policy threats facing physicians in 2027
2
From skin scan to prescription: AI acne prescribing launches in Utah
3
Do food-is-medicine programs work long term? Study links weekly groceries to lower blood pressure
4
More and more patients are paying cash for GLP-1s
5